Stability and in vitro drug release of flurbiprofen-loaded poly-ε- caprolactone nanospheres

Drug Development and Industrial Pharmacy

Volumn 25, Issue 9, 1999, Pages 983-993

  Lacoulonche, F ^a   Gamisans, F ^b   Chauvet, A ^a   Garcia M L ^b   Espina, M ^b   Egea, M A ^b  

^a UNIV MONTPELLIER   (France)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

In vitro release; Nanospheres; Ocular drug delivery; Poly caprolactone; Stability; Thermal methods

Indexed keywords

FLURBIPROFEN; NANOPARTICLE; POLYCAPROLACTONE;

AQUEOUS SOLUTION; ARTICLE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; IN VITRO STUDY; PH; PHYSICAL CHEMISTRY; TECHNIQUE; TEMPERATURE; THERMAL ANALYSIS;

ADMINISTRATION, TOPICAL; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; FLURBIPROFEN; HEXANOIC ACIDS; HYDROGEN-ION CONCENTRATION; LACTONES; MICROSPHERES; POLYMERS; TEMPERATURE; TIME FACTORS;

EID: 0032852048     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100102261     Document Type: Article

References (21)

1. A. Zimmer, E. Mutschler, G. Lambrecht, D. Mayer, and J. Kreuter, Pharm. Res., 11(10), 1435-1442 (1994).
2. V. Masson, P. Billardon, H. Fessi, J. P. Devissaguet, and F. Puisieux, Proc. Int. Symp. Controlled Release Bioact. Mater., 19, 423-424 (1992).
3. J. Valero, M. A. Egea, M. Espina, F. Gamisans, and M. L. García, Drug Dev. Ind. Pharm., 22(2), 167-173 (1996).
4. C. Losa, P. Calvo, E. Castro, L. Vila-Jato, and M. J. Alonso, J. Pharm. Pharmacol., 43, 548-552 (1991).
5. H. Fessi, J. P. Devissaguet, F. Pusieux, and C. Thies, Procédé de préparation de systémes colloidaux dispersibles d'une substance sous forme de nanoparticles, French patent 2608988, 1988.
6. F. Puisieux, in Formes pharmaceutiques (P. Buri, F. Puisieux, E. Doelker, and J. P. Benoit, Eds.), Lavoisier, Tech. et Doc., Paris, 1985, p. 314.
7. H. Marchal-Heussler, H. Fessi, J. P. Devissaguet, M. Hoffman, and P. Maincent, STP Pharma. Sci., 2(1), 98-104 (1992).
8. V. Masson, F. Maurin, J. P. Devissaguet, and H. Fessi, Int. J. Pharm., 139, 113-123 (1996).
9. M. L. McConnell, Anal. Chem., 53, 1007A-1018A (1981).
10. H. Fessi, F. Pusieux, J. P. Devissaguet, N. Ammoury, and S. Benita, Int. J. Pharm., 55, R1-R4 (1989).
11. A. Chiarini, A. Tartarini, and A. Fini, Arch. Pharm. (Weinheim), 317, 268-273 (1984).
12. B. Magenheim and S. Benita, STP Pharma. Sci., 1(4), 221-241 (1991).
13. M. D. Coffin and J. W. McGinity, Pharm. Res., 2(9), 200-205 (1992).
14. V. Masson, F. Maurin, H. Fessi, and J. P. Devissaguet, Biomaterials, 4(18), 327-335 (1997).
15. C. G. Pitt, Poly-ε-caprolactone and its copolymers, in Biodegradable Polymers as Drug Delivery Systems (M. Chasin and R. Langer, Eds.), Marcel Dekker, New York, 1990, pp. 71-120.
16. F. Gamisans, F. Lacoulonche, A. Chauvet, M. Espina, M. L. García, and M. A. Egea, Int. J. Pharm. (submitted).
17. B. Wunderlich, in Thermal Characterization of Polymeric Materials, 2nd ed., Edith A. Turi, New York, 1985, pp. 373-377.
18. Y. C. Martin, in Physical Chemical Properties of Drugs (S. H. Yalkowsky, A. A. Sinkula, and S. C. Valvani, Eds.), Marcel Dekker, New York, 1980, p. 50.
19. C. Washington, Int. J. Pharm., 58, 1-12 (1990).
20. B. Martinez, F. Lairion, M. B. Pena, P. di Rocco, and M. C. Nacucchio, J. Microencapsulation, 2(14), 155-161 (1997).
21. S. Benita, A. Barkai, and Y. V. Pathak, J. Controlled Release, 12, 213-222 (1990).